Tech Company Financing Transactions

Reata Pharmaceuticals Funding Round

Reata Pharmaceuticals closed a $12 million venture capital round on 11/11/2004. Backers included Cardinal Venture Capital and Spinner Global Technology Fund.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
This financing enables us to advance several of our promising anticancer drug candidates into clinical development.

Company Information

Company Status
Mailing Address
2801 Gateway Dr. 150
Irving, TX 75063
Email Address
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) is a biopharmaceutical company focused on developing novel treatments for cancer, inflammation, and neurodegenerative diseases.
Reata Pharmaceuticals LinkedIn Company Profile
Social Media
Reata Pharmaceuticals Company Twitter Account
Company News
Reata Pharmaceuticals News
Reata Pharmaceuticals on Facebook
Reata Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Warren Huff
  Warren Huff LinkedIn Profile  Warren Huff Twitter Account  Warren Huff News  Warren Huff on Facebook
Chief Financial Officer
Jason Wilson
  Jason Wilson LinkedIn Profile  Jason Wilson Twitter Account  Jason Wilson News  Jason Wilson on Facebook
Chief Medical Officer
Colin Meyer
  Colin  Meyer LinkedIn Profile  Colin  Meyer Twitter Account  Colin  Meyer News  Colin  Meyer on Facebook
VP - Bus. Development
Dawn Bir
  Dawn Bir LinkedIn Profile  Dawn Bir Twitter Account  Dawn Bir News  Dawn Bir on Facebook
VP - Bus. Development
Keith Ward
  Keith Ward LinkedIn Profile  Keith Ward Twitter Account  Keith Ward News  Keith Ward on Facebook
VP - Finance
Elaine Castellanos
  Elaine Castellanos LinkedIn Profile  Elaine Castellanos Twitter Account  Elaine Castellanos News  Elaine Castellanos on Facebook
VP - General Counsel
Michael Wortley
  Michael Wortley LinkedIn Profile  Michael Wortley Twitter Account  Michael Wortley News  Michael Wortley on Facebook
VP - Marketing
David Chapman
  David Chapman LinkedIn Profile  David Chapman Twitter Account  David Chapman News  David Chapman on Facebook
VP - R & D
Christian Wigley
  Christian Wigley LinkedIn Profile  Christian Wigley Twitter Account  Christian Wigley News  Christian Wigley on Facebook
VP - Regulatory Affairs
Joel Proksch
  Joel Proksch LinkedIn Profile  Joel Proksch Twitter Account  Joel Proksch News  Joel Proksch on Facebook



Browse more venture capital transactions:

Prev: 11/10/2004: TradeBeam Holdings venture capital transaction
Next: 11/15/2004: CA Technologies venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary